Curanex Pharmaceuticals (NASDAQ:CURX) Releases Earnings Results

Curanex Pharmaceuticals (NASDAQ:CURX) announced its quarterly earnings data on Thursday. The company reported ($0.11) earnings per share for the quarter, FiscalAI reports.

Curanex Pharmaceuticals Stock Performance

CURX stock traded down $0.01 during midday trading on Thursday, reaching $0.31. 102,329 shares of the company were exchanged, compared to its average volume of 116,223. Curanex Pharmaceuticals has a 1-year low of $0.26 and a 1-year high of $9.18. The stock’s 50-day simple moving average is $0.43 and its 200 day simple moving average is $0.42. The company has a market cap of $8.79 million and a price-to-earnings ratio of -1.82.

Analyst Ratings Changes

Separately, Weiss Ratings raised Curanex Pharmaceuticals from a “sell (e)” rating to a “sell (e+)” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Curanex Pharmaceuticals stock. Citadel Advisors LLC bought a new stake in Curanex Pharmaceuticals Inc (NASDAQ:CURX) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 64,067 shares of the company’s stock, valued at approximately $46,000.

About Curanex Pharmaceuticals

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.